CATHETER MANAGEMENT OF ATRIAL SEPTAL DEFECT

Course overview

TRANSCATHETER CLOSURE OF THE ASD IS CURRENTLY AVAILABLE FOR SECUNDUM TYPE OF ASDS, AND CURRENTLY, THERE ARE TWO FDA-APPROVED DEVICES IN THE UNITED STATES FOR THE CLOSURE OF ASD. THIS ACTIVITY REVIEWS THE TECHNIQUE OF ASD CLOSURE, INDICATIONS, CONTRAINDICATIONS AND HIGHLIGHTS THE INTERPROFESSIONAL TEAM'S ROLE IN MANAGING PATIENTS WITH CONGENITAL HEART DEFECTS.